Rs. 111 million contract awarded to supply 1.1 million bags of dialysis medicines

Daily Mirror and Newswire report that the Cabinet approved procurement of 1.1 million bags of medicine used in dialysis treatment for people with kidney failure. Daily Mirror values the contract at Rs. 111.1 million, while Newswire reports a value of Rs. 990 million.

Newswire reports that two bids were received through an international competitive procurement process for the dialysis medicine. Following evaluation and a recommendation by the High-Level Procurement Committee, the Cabinet approved awarding the contract to Infuxion Lanka (Private) Limited, with the medicine to be manufactured by Malaysia’s Peritone Health SDN BHD.

Newswire also reports Cabinet approval for a separate contract to procure 54,000 vials of Liposomal Amphotericin B, each containing 50 mg. The medicine is used to treat serious infections, including cryptococcal meningitis and visceral leishmaniasis.

Newswire says three bids were received for that procurement and that the contract was awarded to India’s Gufic Biosciences Ltd, which will manufacture the medicine. The contract is valued at USD 702,000, including cost and air-freight charges. Newswire reports that both contracts went to the lowest substantially responsive bidders following proposals from the Minister of Health and Mass Media.

Written automatically by AI from the outlets’ own reports, and not reviewed by an editor. It can be wrong — the original report is the authority.